144 related articles for article (PubMed ID: 38679202)
41. Chest wall and rib irradiation and toxicities of early-stage lung cancer patients treated with CyberKnife stereotactic body radiotherapy.
Podder T; Biswas T; Yao M; Zhang Y; Kim E; Ellis RJ; Lo SS; Machtay M
Future Oncol; 2014 Dec; 10(15):2311-7. PubMed ID: 25525841
[TBL] [Abstract][Full Text] [Related]
42. Predictors and management of chest wall toxicity after lung stereotactic body radiotherapy.
Shaikh T; Turaka A
Cancer Treat Rev; 2014 Dec; 40(10):1215-20. PubMed ID: 25261888
[TBL] [Abstract][Full Text] [Related]
43. Dosimetric predictors of chest wall pain after lung stereotactic body radiotherapy.
Creach KM; El Naqa I; Bradley JD; Olsen JR; Parikh PJ; Drzymala RE; Bloch C; Robinson CG
Radiother Oncol; 2012 Jul; 104(1):23-7. PubMed ID: 22385795
[TBL] [Abstract][Full Text] [Related]
44. Dosimetric predictors for genitourinary toxicity in MR-guided stereotactic body radiation therapy (SBRT): Substructure with fraction-wise analysis.
Pham J; Neilsen BK; Liu H; Cao M; Yang Y; Sheng K; Ma TM; Kishan AU; Ruan D
Med Phys; 2024 Jan; 51(1):612-621. PubMed ID: 38055353
[TBL] [Abstract][Full Text] [Related]
45. Treatment of non-small cell lung cancer patients with proton beam-based stereotactic body radiotherapy: dosimetric comparison with photon plans highlights importance of range uncertainty.
Seco J; Panahandeh HR; Westover K; Adams J; Willers H
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):354-61. PubMed ID: 21985941
[TBL] [Abstract][Full Text] [Related]
46. Calculating the individualized fraction regime in stereotactic body radiotherapy for non-small cell lung cancer based on uncomplicated tumor control probability function.
Lu JY; Lin PX; Huang BT
Radiat Oncol; 2019 Jun; 14(1):111. PubMed ID: 31221159
[TBL] [Abstract][Full Text] [Related]
47. Clinical prognostic factors and grading system for rib fracture following stereotactic body radiation therapy (SBRT) in patients with peripheral lung tumors.
Kim SS; Song SY; Kwak J; Ahn SD; Kim JH; Lee JS; Kim WS; Kim SW; Choi EK
Lung Cancer; 2013 Feb; 79(2):161-6. PubMed ID: 23182662
[TBL] [Abstract][Full Text] [Related]
48. Stereotactic ablative radiotherapy: a potentially curable approach to early stage multiple primary lung cancer.
Chang JY; Liu YH; Zhu Z; Welsh JW; Gomez DR; Komaki R; Roth JA; Swisher SG
Cancer; 2013 Sep; 119(18):3402-10. PubMed ID: 23798353
[TBL] [Abstract][Full Text] [Related]
49. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785
[TBL] [Abstract][Full Text] [Related]
50. Local control and toxicity after magnetic resonance imaging (MR)-guided single fraction lung stereotactic ablative radiotherapy.
Tekatli H; Palacios MA; Schneiders FL; Haasbeek CJA; Slotman BJ; Lagerwaard FJ; Senan S
Radiother Oncol; 2023 Oct; 187():109823. PubMed ID: 37516364
[TBL] [Abstract][Full Text] [Related]
51. Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors.
Trakul N; Chang CN; Harris J; Chapman C; Rao A; Shen J; Quinlan-Davidson S; Filion EJ; Wakelee HA; Colevas AD; Whyte RI; Dieterich S; Maxim PG; Hristov D; Tran P; Le QT; Loo BW; Diehn M
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):231-7. PubMed ID: 22381907
[TBL] [Abstract][Full Text] [Related]
52. Chest Wall Toxicity After Stereotactic Body Radiation Therapy: A Pooled Analysis of 57 Studies.
Ma JT; Liu Y; Sun L; Milano MT; Zhang SL; Huang LT; Jing W; Zhao JZ; Han CB; Kong FS
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):843-850. PubMed ID: 30496884
[TBL] [Abstract][Full Text] [Related]
53. Technical Note: Dosimetric evaluation of Monte Carlo algorithm in iPlan for stereotactic ablative body radiotherapy (SABR) for lung cancer patients using RTOG 0813 parameters.
Pokhrel D; Badkul R; Jiang H; Kumar P; Wang F
J Appl Clin Med Phys; 2015 Jan; 16(1):5058. PubMed ID: 25679161
[TBL] [Abstract][Full Text] [Related]
54. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers.
Onimaru R; Shirato H; Shimizu S; Kitamura K; Xu B; Fukumoto S; Chang TC; Fujita K; Oita M; Miyasaka K; Nishimura M; Dosaka-Akita H
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):126-35. PubMed ID: 12694831
[TBL] [Abstract][Full Text] [Related]
55. Dose escalation in extracranial stereotactic ablative radiotherapy (DESTROY-1): A multiarm Phase I trial.
Deodato F; Macchia G; Cilla S; Ianiro A; Sallustio G; Cammelli S; Buwenge M; Mattiucci GC; Valentini V; Morganti AG
Br J Radiol; 2019 Feb; 92(1094):20180422. PubMed ID: 30325662
[TBL] [Abstract][Full Text] [Related]
56. Feasibility study of stereotactic body radiotherapy for peripheral lung tumors with a maximum dose of 100 Gy in five fractions and a heterogeneous dose distribution in the planning target volume.
Takeda A; Oku Y; Sanuki N; Eriguchi T; Aoki Y; Enomoto T; Kaneko T; Nishimura S; Kunieda E
J Radiat Res; 2014 Sep; 55(5):988-95. PubMed ID: 24833770
[TBL] [Abstract][Full Text] [Related]
57. Hypofractionated image-guided breath-hold SABR (stereotactic ablative body radiotherapy) of liver metastases--clinical results.
Boda-Heggemann J; Dinter D; Weiss C; Frauenfeld A; Siebenlist K; Attenberger U; Ottstadt M; Schneider F; Hofheinz RD; Wenz F; Lohr F
Radiat Oncol; 2012 Jun; 7():92. PubMed ID: 22710033
[TBL] [Abstract][Full Text] [Related]
58. Stereotactic body radiation therapy (SBRT) for lung malignancies: preliminary toxicity results using a flattening filter-free linear accelerator operating at 2400 monitor units per minute.
Prendergast BM; Dobelbower MC; Bonner JA; Popple RA; Baden CJ; Minnich DJ; Cerfolio RJ; Spencer SA; Fiveash JB
Radiat Oncol; 2013 Nov; 8():273. PubMed ID: 24256563
[TBL] [Abstract][Full Text] [Related]
59. Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer.
Haasbeek CJ; Lagerwaard FJ; Slotman BJ; Senan S
J Thorac Oncol; 2011 Dec; 6(12):2036-43. PubMed ID: 21892102
[TBL] [Abstract][Full Text] [Related]
60. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
